Search results
Results from the WOW.Com Content Network
Flurpiridaz F-18 is a fluorine 18-labeled agent developed by Lantheus Medical Imaging for the diagnosis of coronary artery disease. [7]The efficacy and safety of flurpiridaz (18 F) were evaluated in two prospective, multicenter, open-label clinical studies in adults with either suspected CAD (Study 1: NCT03354273) or known or suspected CAD (Study 2: NCT01347710). [3]
Florbetapir (18 F), sold under the brand name Amyvid, is a PET scanning radiopharmaceutical compound containing the radionuclide fluorine-18 that was approved for use in the United States in 2012, [4] as a diagnostic tool for Alzheimer's disease.
The [18 F]FDG-6-phosphate formed when [18 F]FDG enters the cell cannot exit the cell before radioactive decay. As a result, the distribution of [18 F]FDG is a good reflection of the distribution of glucose uptake and phosphorylation by cells in the body. [citation needed] The fluorine in [18 F]FDG decays radioactively via beta-decay to 18 O −.
Fluorine-18 (18 F, also called radiofluorine) is a fluorine radioisotope which is an important source of positrons. It has a mass of 18.0009380(6) u and its half-life is 109.771(20) minutes. It decays by positron emission 96.7% of the time and electron capture 3.3% of the time. Both modes of decay yield stable oxygen-18.
[18 F] or [11 C] Flumazenil [18 F] Flutemetamol [18 F] Fluorodopa [18 F] Desmethoxyfallypride [18 F] Mefway [18 F] MPPF [18 F] Nifene [11 C] Pittsburgh compound B [11 ...
Fluoroethyl-l-tyrosine (18 F) commonly known as [18 F]FET, is a radiopharmaceutical tracer used in positron emission tomography (PET) imaging.This synthetic amino acid, labeled with the radioactive isotope fluorine-18, is a valuable radiopharmaceutical tracer for use in neuro-oncology for diagnosing, planning treatment, and following up on brain tumors such as gliomas.
Flortaucipir (18 F) is a radioactive diagnostic agent for adults with cognitive impairment who are being evaluated for Alzheimer's disease. [1]It is indicated for positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs), a primary marker of Alzheimer's disease.
Florbetaben, sold under the brand name Neuraceq, is a diagnostic radiotracer developed for routine clinical application to visualize β-amyloid plaques in the brain. It is a fluorine-18 (18 F)-labeled stilbene derivative.